Molecular characterisation of acquired and overproduced chromosomal blaAmpC in Escherichia coli clinical isolates
- 1 January 2016
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 47 (1) , 62-68
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Molecular epidemiology, resistance profiles and clinical features in clinical plasmid-mediated AmpC-producing EnterobacteriaceaeInternational Journal of Medical Microbiology, 2013
- An Increase in the Clinical Isolation of Acquired AmpC β-Lactamase-Producing Klebsiella pneumoniae in Korea from 2007 to 2010Annals of Laboratory Medicine, 2013
- Spanish Multicenter Study of the Epidemiology and Mechanisms of Amoxicillin-Clavulanate Resistance in Escherichia coliAntimicrobial Agents and Chemotherapy, 2012
- Association of blaDHA-1 and qnrB genes carried by broad-host-range plasmids among isolates of Enterobacteriaceae at a Spanish hospitalClinical Microbiology and Infection, 2011
- Emergence of Ertapenem Resistance in an Escherichia coli Clinical Isolate Producing Extended-Spectrum β-Lactamase AmpCAntimicrobial Agents and Chemotherapy, 2011
- Detection of AmpC Beta-Lactamase in Escherichia coli: Comparison of Three Phenotypic Confirmation Assays and Genetic AnalysisJournal of Clinical Microbiology, 2011
- Phenotypic and Biochemical Comparison of the Carbapenem-Hydrolyzing Activities of Five Plasmid-Borne AmpC β-LactamasesAntimicrobial Agents and Chemotherapy, 2010
- Clinical Features and Molecular Epidemiology of CMY‐Type β‐Lactamase–ProducingEscherichia coliClinical Infectious Diseases, 2009
- AmpC β-LactamasesClinical Microbiology Reviews, 2009
- Identification of plasmids by PCR-based replicon typingJournal of Microbiological Methods, 2005